Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Melanoma 89%
3. Breast 66%
4. Mastectomy 62%
5. Sentinel Lymph Node 50%
6. Neoplasms 42%
7. Neoadjuvant Therapy 37%
8. Mammaplasty 35%
9. Carcinoma, Intraductal, Noninfiltrating 32%
10. Lymph Nodes 30%
11. Large-Core Needle Biopsy 28%
12. Lymph Node Excision 27%
13. Axilla 24%
14. Sentinel Lymph Node Biopsy 23%
15. Phyllodes Tumor 23%
16. Skin 22%
17. Recurrence 22%
18. Drug Therapy 19%
19. Survival 18%
20. Neoplasm Metastasis 17%
21. Segmental Mastectomy 17%
22. Surgeons 17%
23. Prophylactic Mastectomy 17%
24. Breast Diseases 16%
25. Biopsy 16%
26. Therapeutics 15%
27. Elderly 14%
28. Guidelines 14%
29. human ERBB2 protein 14%
30. Brachytherapy 13%
31. Male Breast Neoplasms 13%
32. Frozen Sections 13%
33. Radiation 12%
34. Integrins 12%
35. Patient Reported Outcome Measures 11%
36. Tissue Expansion Devices 11%
37. Hyperplasia 10%
38. Fine Needle Biopsy 9%
39. Lobular Carcinoma 9%
40. Breast Carcinoma In Situ 9%
41. Inflammatory Breast Neoplasms 9%
42. Pathology 9%
43. Anastrozole 8%
44. Radiotherapy 8%
45. Cutaneous Malignant Melanoma 8%
46. Mammography 8%
47. Surgical Oncology 7%
48. Ultrasonography 7%
49. Dissection 7%